NasdaqCM:NEOHealthcare
Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness
NeoGenomics (NEO) has drawn attention after its share price closed at $8.24, with recent returns showing pressure over the past month and past 3 months, prompting investors to reassess the cancer testing specialist.
See our latest analysis for NeoGenomics.
The recent 1 day share price return of 4.57% comes after a 30 day share price decline of 27.59% and a 1 year total shareholder return of 16.26% in the red. This indicates that pressure has been building for some time rather than momentum...